Rocket Pharmaceuticals(RCKT) - 2021 Q2 - Earnings Call Presentation

Corporate Presentation S E E K I N G G E N E T H E R A P Y C U R E S August 2021 1 NASDAQ: RCKT Important Information 2 Cautionary Statement Regarding Forward-Looking Statements Various statements in this release concerning Rocket's future expectations, plans and prospects, including without limitation, Rocket's expectations regarding its guidance for 2020 in light of COVID-19, the safety, effectiveness and timing of product candidates that Rocket may develop, to treat Fanconi Anemia (FA), Leukocyte Adhesio ...